| IGF-1 | Insulin-like growth factor 1 |
| IGF-2 | Insulin-like growth factor 2 |
| ECM | Extracellular matrix |
| IR | Insulin receptor |
| IGF-1R | Insulin-like growth factor receptor 1 |
| IGF-2R | Insulin-like growth factor receptor 2 |
| DMRs | Differentially methylated regions |
| ICR | Imprinting control region |
| CTCF | CCCTC-binding factor |
| BWS | Beckwith–Wiedemann Syndrome |
| RSS | Russell–Silver syndrome |
| CI-MPR | Cation-independent mannose-6-phosphate receptor |
| CD-MPR | Cation-dependent mannose-6-phosphate receptor |
| GSK3 | Glycogen synthase kinase 3 |
| MAPK | Mitogen-activated protein kinase |
| PI3K | Phosphatidylinositol-3-kinase |
| Akt | Protein kinase B |
| IRS | Insulin receptor substrates |
| mTOR | Mammalian target of rapamycin |
| ERK | Extracellular-regulated protein kinase |
| c-fos | Fos proto-oncogene, AP-1 transcription factor subunit |
| c-jun | Jun proto-oncogene, AP-1 transcription factor subunit |
| EGFR | Epidermal growth factor receptor |
| HER2 (ERB2) | Erb-b2 receptor tyrosine kinase 2 |
| HER (ERBB3) | Erb-b2 receptor tyrosine kinase 3 |
| SSc | Systemic sclerosis |
| IPF | Idiopathic pulmonary fibrosis |
| JNK (MAPK8) | Mitogen-activated protein kinase 8 |
| AP-1 | Activator protein 1 |
| ATF-2 | Activating transcription factor 2 |
| MMP | Matrix metalloproteinase |
| Ang II | Angiotensin II |
| TIMP | Tissue inhibitor of metalloprotease |
| Gaq (GNAQ) | G protein subunit alpha q |
| PLC-β | Phospholipase C beta |
| PA | Plasminogen activator |
| CaMKIIδ | Calcium/calmodulin-dependent protein kinase II |
| HSC | Hepatic stellate cell |
| CCl4 | Carbon tetrachloride |
| 2-FAA | 2-fluorenylacetamide |
| α-SMA | α-smooth muscle actin |
| CKD | Chronic kidney disease |
| CTGF | Connective tissue growth factor |
| BMP | Bone morphogenetic protein |
| PDGF | Platelet-derived growth factor |
| OSF | Oral submucosal fibrosis |